Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Comfort × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2 Plasma cell 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Lymphoid 1 Head & Neck 1 Gastrointestinal 1

Conditions

Multiple Myeloma 1 Lymphoma 1

Interventions

Rituximab 1191 Cyclophosphamide 1112 Vincristine 560 Doxorubicin 501 Etoposide 451 Prednisone 426 Cytarabine 408 fludarabine 404 Methotrexate 362 Dexamethasone 340 fludarabine phosphate 332 Lenalidomide 309 Filgrastim 297 Bendamustine Hydrochloride 237 Radiotherapy 231 venetoclax 222 ibrutinib 214 obinutuzumab 202 Melphalan 192 Peripheral Blood Stem Cell Transplantation 190 Granulocyte Colony-Stimulating Factor 176 Gemcitabine 170 Bortezomib 165 Busulfan 159 Whole-Body Irradiation 157 Mycophenolic Acid 145 Tacrolimus 125 Magnetic Resonance Spectroscopy 124 pegaspargase 122 Specimen Handling 121

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed

51 enrolled 8 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡